Maureen Legendre

1.2k total citations
24 papers, 843 citations indexed

About

Maureen Legendre is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Maureen Legendre has authored 24 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Hematology. Recurrent topics in Maureen Legendre's work include Nuclear Structure and Function (7 papers), Acute Myeloid Leukemia Research (5 papers) and Legionella and Acanthamoeba research (5 papers). Maureen Legendre is often cited by papers focused on Nuclear Structure and Function (7 papers), Acute Myeloid Leukemia Research (5 papers) and Legionella and Acanthamoeba research (5 papers). Maureen Legendre collaborates with scholars based in United States, Germany and China. Maureen Legendre's co-authors include Joan K. Brieland, David M. Markovitz, Joseph C. Fantone, Nirit Mor‐Vaknin, Mark S. McClain, N. Cary Engleberg, Daniel G. Remick, Ferdinand Kappes, Cary Engleberg and Barbara S. Adams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Maureen Legendre

22 papers receiving 827 citations

Peers

Countries citing papers authored by Maureen Legendre

Since Specialization

Citations

This map shows the geographic impact of Maureen Legendre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Legendre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Legendre more than expected).

Fields of papers citing papers by Maureen Legendre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Legendre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Legendre. The network helps show where Maureen Legendre may publish in the future.

Co-authorship network of co-authors of Maureen Legendre

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Legendre. A scholar is included among the top collaborators of Maureen Legendre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Legendre. Maureen Legendre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion 2025 ·PLoS Pathogens ·Meng Yu, (unknown), Faezzah Baharom, Shuijie Li, Maureen Legendre, (unknown), Ebba Sohlberg, Susanne Schlisio, Karin Loré, David M. Markovitz, Anna Smed‐Sörensen	0
2	Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma 2023 ·Journal for ImmunoTherapy of Cancer ·Mary K. McKenna, (unknown), Daniel Brenner, Norihiro Watanabe, Maureen Legendre, Dafydd G. Thomas, Christopher Ashwood, Richard D. Cummings, Challice L. Bonifant, David M. Markovitz, Malcolm K. Brenner	30
3	H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice 2022 ·Scientific Reports ·(unknown), (unknown), Maureen Legendre, David M. Markovitz, Jennifer F. Moffat	13
4	DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling 2022 ·Journal of Leukocyte Biology ·Maegan L. Capitano, (unknown), James Ropa, Maureen Legendre, Nirit Mor‐Vaknin, David M. Markovitz	5
5	Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity 2021 ·Scientific Reports ·(unknown), Steven King, Maureen Legendre, Michael D. Swanson, (unknown), Sandra Claes, Jennifer L. Meagher, (unknown), Lihong Zhang, Birte Kalveram, (unknown), Alexander N. Freiberg, Mark N. Prichard, Jeanne A. Stuckey, Dominique Schols, David M. Markovitz	18
6	A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo 2020 ·Proceedings of the National Academy of Sciences ·(unknown), Steven R. King, Maureen Legendre, (unknown), Susana M. Chan, (unknown), (unknown), (unknown), Donald F. Smee, Elke Lipka, Scott E. Evans, E. Bart Tarbet, Akira Ono, David M. Markovitz	55
7	Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis 2020 ·Lupus ·(unknown), Matthew D. Cascino, Jian Dai, (unknown), Kichul Ko, (unknown), Leonard L. Dragone, (unknown), Maureen Legendre, David M. Markovitz, (unknown), Michael J. Townsend, Marcus R. Clark	7
8	Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin 2019 ·PLoS neglected tropical diseases ·(unknown), Julie Dyall, Lisa Evans DeWald, Steven R. King, Derek Dube, Maureen Legendre, Elizabeth A. Nelson, (unknown), Robin Gross, (unknown), (unknown), Elena Postnikova, Janie Liang, (unknown), Jagathpala Shetty, Lisa E. Hensley, Peter B. Jahrling, Gene G. Olinger, Judith M. White, David M. Markovitz	34
9	Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling 2019 ·PMC ·Maegan L. Capitano, Nirit Mor‐Vaknin, Anjan K. Saha, Scott Cooper, Maureen Legendre, Haihong Guo, Rafael Contreras-Galindo, Ferdinand Kappes, Maureen A. Sartor, (unknown), Xinxin Huang, David M. Markovitz, Hal E. Broxmeyer	2
10	Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling 2019 ·Journal of Clinical Investigation ·Maegan L. Capitano, Nirit Mor‐Vaknin, Anjan K. Saha, Scott Cooper, Maureen Legendre, Haihong Guo, Rafael Contreras-Galindo, Ferdinand Kappes, Maureen A. Sartor, Christopher T. Lee, Xinxin Huang, David M. Markovitz, Hal E. Broxmeyer	27
11	DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis 2017 ·Nature Communications ·Nirit Mor‐Vaknin, Anjan K. Saha, Maureen Legendre, Carmelo Carmona‐Rivera, M. Asif Amin, Bradley J. Rabquer, (unknown), Julie M. Jorns, (unknown), Srilakshmi Yalavarthi, Dave A. Pai, (unknown), (unknown), Jason S. Knight, Barbara S. Adams, Alisa E. Koch, David A. Fox, David R. Engelke, Mariana J. Kaplan, David M. Markovitz	83
12	Murine Colitis is Mediated by Vimentin 2013 ·Scientific Reports ·Nirit Mor‐Vaknin, Maureen Legendre, Yue Yu, C. Henrique Serezani, Sanjay K. Garg, (unknown), Michael D. Swanson, Marta J. Gonzalez-Hernandez, Seagal Teitz‐Tennenbaum, Antonello Punturieri, N. Cary Engleberg, Ruma Banerjee, Marc Peters‐Golden, John Y. Kao, David M. Markovitz	51
13	DEK Regulates Hematopoietic Stem Engraftment and Progenitor Cell Proliferation 2011 ·Stem Cells and Development ·Hal E. Broxmeyer, Ferdinand Kappes, Nirit Mor‐Vaknin, Maureen Legendre, (unknown), Scott Cooper, Giao Hangoc, David M. Markovitz	34
14	DEK Regulates Hematopoietic Stem Engraftment and Progenitor Cell Proliferation 2011 ·Blood ·Hal E. Broxmeyer, (unknown), Nirit Mor‐Vaknin, Maureen Legendre, (unknown), Scott Cooper, Giao Hangoc, David M. Markovitz	2
15	DEK in the synovium of patients with juvenile idiopathic arthritis: Characterization of DEK antibodies and posttranslational modification of the DEK autoantigen 2010 ·Arthritis & Rheumatism ·Nirit Mor‐Vaknin, Ferdinand Kappes, (unknown), Maureen Legendre, (unknown), Seagal Teitz‐Tennenbaum, Roland P.S. Kwok, Elisa Ferrando‐May, Barbara S. Adams, David M. Markovitz	58
16	The DEK Nuclear Autoantigen Is a Secreted Chemotactic Factor 2006 ·Molecular and Cellular Biology ·Nirit Mor‐Vaknin, Antonello Punturieri, Kajal Sitwala, (unknown), Maureen Legendre, Michael S. Khodadoust, Ferdinand Kappes, Jeffrey H. Ruth, Alisa E. Koch, David N. Glass, Lilli Petruzzelli, Barbara S. Adams, David M. Markovitz	76
17	In Vivo Regulation of ReplicativeLegionella pneumophilaLung Infection by Endogenous Interleukin-12 1998 ·Infection and Immunity ·Joan K. Brieland, Daniel G. Remick, Maureen Legendre, N. Cary Engleberg, Joseph C. Fantone	59
18	Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts 1996 ·Infection and Immunity ·(unknown), Clarence E. Chrisp, Gary B. Huffnagle, Maureen Legendre, Yoichi Osawa, Mary C. Hurley, Cary Engleberg, Joseph C. Fantone, Joan K. Brieland	38
19	Coinoculation with Hartmannella vermiformis enhances replicative Legionella pneumophila lung infection in a murine model of Legionnaires' disease 1996 ·Infection and Immunity ·Joan K. Brieland, Mark S. McClain, (unknown), Clarence E. Chrisp, Gary B. Huffnagle, Maureen Legendre, Mary C. Hurley, Joseph C. Fantone, Cary Engleberg	56
20	Severe heparin and pentosan polysulfate - induced thrombocytopenias : Clinical aspects - in vitro effects of pentosan polysulfate, low molecular weight (LMW) heparins and oligosaccharides 1986 ·Thrombosis Research ·J.Y. Borg, (unknown), Maureen Legendre, F Toulemonde, H Piguet, M. Monconduit	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact